Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT02108899
Other study ID # 5305
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date December 2022

Study information

Verified date June 2022
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

When people are tested on a previously learned material, they will later remember it better even when compared to a condition where they can re-study it. This phenomenon is called retrieval practice and is supported by an extensive research literature mostly carried out in normal students. This paradigm begins to be used in cognitive remediation programs in patients suffering from memory difficulties. The objective of this study is to investigate whether retrieval practice is spared in patients with schizophrenia. If effective, this method could be used in cognitive remediation programs. Since episodic memory difficulties are supposed to be secondary to deficits in the initiation/elaboration of efficient encoding and retrieval strategies our hypothesis is that retrieval practice is spared in schizophrenia.


Recruitment information / eligibility

Status Suspended
Enrollment 50
Est. completion date December 2022
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - French is the native language, or acquired before 5 years old - People must be able to understand and follow the trial instructions Specific inclusion criteria (for patients) : - Diagnostic of schizophrenia, according to the DSM -5, clinically stable - The treatment must remain unchanged during the trial Exclusion Criteria: - Severe or acute cerebral disease - Other actual psychiatric disorder - Use of drugs with high anticholinergic effect - Irregular use of benzodiazepines medication, or high dose of benzodiazepin (more than 2 mg of lorazepam per day or equivalent) - Inappropriate use of drugs Specific exclusion criteria (for healthy subjects) : - Diagnostic of schizophrenia of a relative up to the third degree

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Retrieval practice effect using descriptive stories and free-call tests without feedback
In the first phase (encoding), people study 2 short prose passages covering general scientific topics. In the second phase (initial test), they recall one text or restudy the other one. In the third phase (final test) which takes place 2 days later, they recall both texts.

Locations

Country Name City State
France Service de psychiatrie - Hôpital Civil - CHRU Strasbourg Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of items properly recalled - The aim is to investigate the retrieval practice effect using descriptive stories and free-recall tests without feedback in patients with schizophrenia and healthy controls.
In the first phase (encoding), people study 2 short prose passages covering general scientific topics.
In the second phase (initial test), they recall one text ("test" condition) or restudy the other one ("re-study" condition).
In the third phase (final test) which takes place 2 days later, they recall both texts.
- We will compare in patients with schizophrenia and healthy controls final performance recall (number of items properly recalled) for information studied and recalled ("test" condition) to those for information studied and then re-studied ("re-study" condition).
Final test : 2 days after the first experimental session
Secondary Difference between final performance recall and memory span score In each group (patients with schizophrenia and healthy controls) :
Difference between the final performance recall (see primary outcome measure) in "test" condition and "re-study" condition AND memory span score.
Final test : 2 days after the first experimental session
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A